has effectively improved the pregnancy rate of patients with oligoasthenozoospermia, it has not fundamentally improved the quality of patients' sperm and increases the risk of foetal growth restriction, low birth weight and neonatal diseases. 10 Multilayered synergetic clinical and basic research should therefore be performed to reveal the etiology and pathogenesis underlying oligoasthenozoospermia, representing the majority of infertility cases.
Oligoasthenozoospermia is a manifestation of spermatogenesis and functional maturation disorders. Spermatogenesis is a complex process in the testis including several important biological events, such as the proliferation of spermatogonia, the meiosis of spermatocytes and spermiogenesis. The spermatozoa produced in the testes
are not yet functionally mature. They have to transit through the epididymis and then acquire their forward motility and their ability to efficiently encounter the egg and its layers. 11 On this basis, revealing the regulatory mechanism of spermatogenesis/sperm function would help to clarify the pathogenesis of oligoasthenozoospermia and is an important issue in male reproductive research.
In recent years, proteomic studies of the human organs have increased our knowledge and understanding of proteins' function.
Proteomics is the systematic study of the proteins contained in a specific cell, tissue or organ. [12] [13] [14] In the process of spermatogenesis and functional maturation, the orderly and specific expression of a gene/protein network plays an important regulatory role and a series of genes/proteins have been identified as related to spermatogenesis and/or sperm function such as T-complex-associated-testis-expressed 1, 2 MORC family CW-type zinc finger 2B, 15 ER membrane protein complex subunit 10, 16 
B lymphoma
Mo-MLV insertion region 1 homolog (mouse), 17 and spermatidspecific protein 411. 18 It is necessary to identify more genes or proteins involved in these processes. In our previous work, a human testis and sperm proteome database was constructed using a proteomics research platform, providing an overall view of the testis and sperm proteins, which helped us to gain insights into the multi-level, multi-perspectives of the protein networks active during spermatogenesis/sperm function. 19, 20 In the present study, we concentrated on a protein expressed in human testis and sperm named tubulin polymerization-promoting protein family member 2 (TPPP2), which has a homologous gene in mice and thus it was feasible to explore the regulatory mechanism of spermatogenesis/sperm function in detail using a Tppp2 knockout mouse model.
There are three TPPP paralogs in the human genome denoted as TPPP/p25, TPPP2/p18 and TPPP3/p20 (shortened to TPPP1, TPPP2
and TPPP3, respectively), indicating their molecular mass. [21] [22] [23] TPPP1 and TPPP3 have been the subjects of several studies. TPPP3 shares the microtubule associated protein-like features of TPPP1, binding and polymerizing tubulin and stabilizing microtubules. [24] [25] [26] TPPP1 is a brain-specific protein that is involved in brain developmental processes. Under pathological conditions, TPPP1 is enriched in glial and neuronal inclusions in the synucleinopathies of Parkinson's disease and multiple system atrophy. [26] [27] [28] TPPP3 is involved in developmental processes of the musculoskeletal system and is a specific marker of the differentiating tendon sheath and synovial joints. 29 These results suggested that TPPP family members might have significant tissue specific expression and thus play an important role in the development and function of specific tissues. Interestingly, it seems that TPPP2 is different from TPPP1 and TPPP3, which are linked to microtubules. Although there has been no study on the function of TPPP2 to date, preliminary experiments in vitro showed that TPPP2 was distributed homogeneously within the cytosol of transfected HeLa cells. 24 In the present study, we found TPPP2 in our human testis and sperm proteome database, which indicated that TPPP2 is likely to play an important role in spermatogenesis and/or sperm function.
This study aimed to use human samples and KO mouse models to explore the function and mechanism of TPPP2. Our results will provide a new perspective on the complex spermatogenesis regulatory networks. We also anticipate providing new targets for male infertility diagnosis and for the development of male contraceptives.
| MATERIAL S AND ME THODS

| Animals
Tppp2 KO mice were generated via Cas9/RNA-mediated gene targeting as described previously. 30 All mice were housed in a specific pathogen-free animal facility with a light:dark cycle of 12:12. All the animal experiments in this study were approved by the Institutional Animal Care and Use Committees of Nanjing Medical University, Nanjing, China.
| Detection of sperm function parameters
| Assessment of sperm motility and sperm count
Sperm were extracted and incubated in human tubal fluid (HTF) medium (EasyCheck, Nanjing, China) at 37°C. Sperm samples were diluted and a 10-μl aliquot of the sperm sample was evenly distributed on a glass chamber slide and analysed using a Computer Assisted Sperm Analyzer (CASA) via the IVOS II™ system (Hamilton Thorne, Beverly, MA, USA).
| Assessment of capacitation and acrosome reaction
The human sperm prepared as described above were capacitated for 5 hours in TYH medium (EasyCheck, Nanjing, China) at 37°C
and 5% CO 2 . Calcium ionophore A23187 (final concentration 10 µmol/L; Sigma-Aldrich, St. Louis, MO, USA) was then added to the capacitated sperm for 30 minutes to induce the acrosome reaction. The percentage of capacitated and acrosome reacted human sperm was evaluated by staining with chlortetracycline (SigmaAldrich). At least 200 sperm were counted under an LSM700 confocal microscope (Carl Zeiss AG, Gottingen, Germany).
| In vitro fertilization assay
The cumulus-oocyte complexes (COCs) were isolated from superovulated female mice 13 hours after Human chorionic gonadotropin (HCG, Sansheng Biological Technology, Ningbo, China) injection.
The COCs in HTF medium (EasyCheck) were mixed with capacitated epididymal sperm and incubated at 37°C under 5% CO 2 , then placed in KSOM medium (EasyCheck) and undisturbed cultivation was performed for 1 day. Developing embryos were determined microscopically based on progression to the two-cell stage. 
| Measurement of sperm ATP
| MMP assay
The mitochondrial membrane potential (MMP) was assessed using 
| Assessment of fertility
To determine the fertility of the animals, a male was mated with two females. The female mouse was separated from the male after the formation of a normal vaginal plug was detected. The number of offspring produced per female was recorded for 6 months.
| Histological analysis
The testes and epididymis tissues were dissected, fixed in modified
Davidson's Fluid and embedded in paraffin. Sections were cut and then stained using hematoxylin and eosin and Periodic Acid-Schiff's technique following our previously published protocols. 2 The seminiferous epithelium cycle (SEC) was characterized using morphological criteria into various developmental stages, primarily based on the form and shape of the acrosome and to a lesser extent, on spermatid head shape and the degree of chromatin condensation. Each stage with a distinct ordering of cell associations along the length of the seminiferous tubule was designated by Roman numerals. 31 All spermatocytes and round spermatids cell nucleoli were counted per animal in five round seminiferous tubule cross-sections at stages VII-VIII of the cycle.
For ultrastructural examination, 2.5% glutaraldehyde-fixed sperm were post-fixed with 2% (wt/vol) OsO4 and embedded in Araldite. Ultrathin sections were stained with uranyl acetate and lead citrate and analysed using electron microscopy (JEOL, Tokyo, Japan).
| Quantitative real-time PCR analysis
Total RNA was extracted from mouse tissues or cells using Trizol Table S1 .
| Western Blotting analysis
Protein levels in mouse tissues or cells were determined by western 
| Immunohistochemistry and immunofluorescence analysis
Prepared mouse tissues or cells were blocked in 1% bovine serum albumin and then incubated overnight at 4°C with anti-TPPP2 antibodies (Abcam, 121215; 1:250). The samples were then incubated with secondary antibodies at room temperature for 2 hours, following our previously published protocols. 17 Slides were viewed under a bright-field microscope (ZEISS Axio Skop plus2) for immunohistochemical analysis and under a LSM700 confocal microscope (Carl Zeiss AG) for immunofluorescent analysis.
| Immunoprecipitation from cell culture extracts
HEK293T cells were transfected with GFP-tagged TPPP2 fusion plasmids using Lipofectomine 2000 (Thermo Fisher Scientific). Two days after transfection, cells were lysed using Pierce IP Lysis Buffer (Thermo Fisher Scientific) supplemented with 1% (vol/vol) protease inhibitor mixture (Selleck, Houston, TX, USA) for 40 minutes at 4°C
and then clarified using centrifugation at 12 000 g for 20 minutes.
The lysates were precleared with 20 μL of Protein A/G magnetic beads (Selleck, Houston, TX, USA) for 1 hour at 4°C. The precleared lysates were incubated overnight with anti-GFP antibodies at 4°C.
Lysates were then incubated with 50 μL of Protein A/G magnetic beads for 3 hours at 4°C. The beads were washed three times with IP Lysis Buffer and eluted with Pierce IgG Elution Buffer (Thermo Fisher Scientific). Samples were boiled in SDS loading buffer before being subjected to SDS/PAGE.
| Mass spectrometry analysis
For mass spectrometry analysis, elution was followed by in-solution digestion. Briefly, elution was first achieved using ultrafiltration with was added to stop the digestion. The peptides were desalted using OASIS HLB Extraction Cartridges (Waters, Milford, MA, USA) before mass spectrometric analysis. We performed MS analyses according to previously published experimental procedures. 2 All raw files were searched using MaxQuant software (version 1.3.0.5, Martinsried, Germany) against the UniProt human proteome database.
| Statistical analysis
All assays were repeated at least three times. Statistical analyses were evaluated using SPSS19.0. The statistical significance of differences in mean values was assessed using a t test. Values of P < 0.05
were considered statistically significant.
| RE SULTS
| Histological expression and cellular localization of TPPP2
RT-PCR revealed the distribution of Tppp2 mRNA in various tissues of mice including the heart, spleen, lung, kidney, brain, epidydimis, testis, uterus, ovary and liver. As shown in Figure 1A , Tppp2 was only expressed in male reproductive organs including the testis and epidydimis. Testis maturation is age-dependent and the first wave of spermatogenesis takes place within 35 post-natal days in mice. We Immunohistochemical analysis of adult mouse epididymides showed that TPPP2 was expressed in sperm, rather than in epithelial cells ( Figure 1D ). Then, immunofluorescence analysis was carried out to identify the localization of TPPP2 in mature sperm. The results
showed that TPPP2 was expressed in the middle piece of the sperm tail ( Figure 1E ).
| Inhibition of TPPP2 impaired sperm motility
To determine whether TPPP2 is associated with sperm function, human sperm were co-incubated with anti-TPPP2 antibodies at
as controls. The results showed that sperm motility in the 20 µg/mL anti-TPPP2 antibody group was reduced significantly compared with that in the control group (P < 0.001); the sperm motility of the 2 µg/ mL and 8 µg/mL anti-TPPP2 antibody groups showed no significant differences (Figure 2A-B) .
We examined the sperm ATP content of the 20 µg/mL anti-TPPP2 antibody treatment group with significantly decreased sperm motility. The results showed that the sperm ATP content in the antibody treatment group was significantly lower than that in the control group ( Figure 2C ) (P < 0.001), suggesting that the decrease in sperm motility after incubation might be caused by a decrease in the ATP content.
In addition, human sperm was incubated with IgG antibody (20 µg/mL) and TPPP2 antibody (20 µg/mL) and then assayed by CTC staining to determine the percentage of capacitated and acrosome-reacted sperm. The results showed that the percentages of capacitated and acrosome-reacted sperm between these two groups
were not significantly different ( Figure 2D ).
The effects of anti-TPPP2 antibody on mouse sperm were also evaluated. As shown in the images, the 20 µg/mL anti-TPPP2 
| Generation of TPPP2 gene KO mice
Gene editing using CRISPR/Cas9 technology combined with microinjection technology was used to construct Tppp2 gene KO mice. The representative Sanger sequence image for the verification of the KO mouse is shown in Figure 4A . After the extraction of DNA, PCR amplification was performed with specific primers ( Figure 4B ). The results confirmed the deletions of targeted regions in Tppp2 −/− male mice, leading to a frame-shift mutation of
Tppp2.
To determine that the TPPP2 protein was not expressed in the testis and sperm of Tppp2 −/− male mice, a series of western blotting, immunohistochemical and immunofluorescence assays were conducted. The results showed that the Tppp2 −/− mouse testis and sperm had no TPPP2 protein expression (Figures 4-9C-F ).
| TPPP2 deficiency impaired sperm motility and count, thus affecting fertility
Mating tests followed by continuous monitoring for six months revealed that Tppp2 −/− males exhibited a subfertile capacity ( Figure 5A) (P < 0.001). Each month's fertility status was analysed and the status of fertility reduction in Tppp2 −/− males was found to be persistent ( Figure 5B ) (for the first month: P < 0.05; for the second, fifth and sixth month: P < 0.01; for the third and fourth month: P < 0.001).
CASA analysis revealed that the sperm counts and sperm motility of Tppp2 −/− male mice were significantly lower than those of the controls ( Figure 5C -E) (for the progressive motility and sperm counts:
P < 0.05; for the total motility: P < 0.01).
The weight and size of the testis did not differ significantly between the WT and Tppp2 −/− mice ( Figure 6A -B). They both had intact spermatogenic tubules and spermatogenic cells at all stages could be seen, which were normal in shape and arranged in an orderly manner without shedding ( Figure 6C ). The number of spermatocytes and round spermatids were counted and there was no significant difference between WT and Tppp2 −/− mouse testes ( Figure 6D ). In addition, apoptosis in the Tppp2 −/− mouse testes was not significantly increased compared with that in the WT controls ( Figure 6E ).
| Abnormal mitochondria and impaired ATP synthesis in Tppp2 −/− male mice sperm
To seek the reason for the decreased sperm motility in the Tppp2 −/− male mice, we first compared the ultrastructure of the sperm from the Tppp2 −/− and wild-type groups using transmission electron microscopy. The results revealed that the Tppp2 −/− mice sperm tails contained normal outer dense fibres and a highly ordered structure, termed the "9 + 2" axoneme, which appeared no different to those of WT mice sperm. However, the mitochondria of Tppp2 −/− -mice sperm were irregular, with a significantly increased proportion of sperm lacking inner mitochondrial membrane (IMM) cristae when compared with those of the wild-type mice ( Figure 7A -B) (P < 0.05).
JC-1 dye has been used to monitor MMP. High membrane potential was associated with emission at 590 nm (red) and low membrane potential at 530 nm (green). Detection of MMP showed that MMP in Tppp2 −/− mice sperm was lower than that in wild-type mice sperm
( Figure 7C-D) . 
| Sperm apoptosis was increased in
| The identification of TPPP2 interacting proteins
A plasmid overexpressing TPPP2 with a GFP label was transfected into HEK293T cell lines. After transfection of the TPPP2 expression plasmid, the cellular proteins were extracted and anti-GFP antibodies were used to detect the transfection efficiency using western blotting. The results showed that TPPP2 protein was diffusely expressed in the cytoplasm of HEK293T cells ( Figure 9A-B ). An immunoprecipitation experiment was carried out with proteins extracted from HEK293T cells transfected with the TPPP2-GFP plasmid and the samples obtained by precipitation were identified using mass spectrometry, which identified eEf1b (eukaryotic translation elongation factor 1 beta) ( Figure 9C ).
The interaction between TPPP2 and eEf1b was verified in testes using immunoprecipitation and western blotting ( Figure 9D ).
| D ISCUSS I ON
The study of spermatogenesis/sperm function regulation is a research hotspot in the field of reproductive medicine. An orderly and specifically expressed gene/protein network may play an important role and a series of genes have been identified as related to spermatogenesis/sperm function. [15] [16] [17] [18] In this study, we paid particular attention to a tubulin polymerization-promoting protein family member, TPPP2, which is likely to play an important role in male reproduction.
Our results indicated that TPPP2 was specifically expressed in male reproductive organs, including testes and epididymis. In testes, TPPP2 was restrictively expressed at stages IV-VIII of the sem- To determine whether TPPP2 plays a role in sperm function, we conducted preliminary validation in sperm in vitro using anti-TPPP2 antibody blocking experiments. The results revealed that after TPPP2 was inhibited, human sperm motility was Therefore, the preliminary in vitro results suggested that TPPP2
could play an important role in sperm function by affecting energy production, leading to the observed changes in sperm motility. There is no doubt that the motility of sperm is directly related to fertilization and only a certain amount of normal progressively motile sperm can cross the barriers in the female genital tract and ensure fertilization of the egg. As mentioned above, male factors account for about 50% of the infertility causes. The prevalence of these male infertility cases was 18.71% for asthenozoospermia and 63.13% for asthenozoospermia associated with oligo-and/ or terato-zoospermia. 4 However, the exact pathogenesis of oligoasthenozoospermia is not clear. TPPP2 is likely to be a potential pathogenic factor in male infertility. To explore the roles of TPPP2 in sperm function, we conducted further studies using
Using Tppp2 −/− mice, we demonstrate that TPPP2 is crucial for male fertility as the litter size of Tppp2 −/− male mice declined significantly. Through further analysis, a significant decrease in sperm motility with a significantly lower ATP content was observed in Tppp2 −/− mice, which was consistent with the results in vitro. In addition, we found that lack of TPPP2 in males caused a significantly reduced sperm count. function. 32 On this basis, we presume that the lack of IMM cristae in Tppp2 −/− male mice has a significant influence on the quality and function of sperm. To confirm this conjecture, we conducted a series of tests.
After staining with JC-1, 33 a significantly decreased MMP in Tppp2 −/− male mice sperm was found, suggesting that mitochondrial function was impaired. In addition, we detected several key markers of ETC complexes including COX2, COX3, MTCYB and MTATP, which are all correlated with ATP synthesis. [34] [35] [36] Their significantly decreased expression levels in Tppp2 −/− male mice sperm suggested that abnormal mitochondria severely affected the energy production and motor function of spermatozoa.
As for the lower sperm counts in Tppp2 −/− male mice, we also explored the possible reasons. We first eliminated the possibility of spermatogenesis disorder in testes by counting spermatogenic cells.
The number of spermatocytes and round spermatids were similar between Tppp2 −/− and wild-type male mice. Besides, our results also revealed no increase in TUNEL-positive cells observed in the testis of Tppp2 −/− male mice. As the decline of MMP is also an iconic event of early apoptosis, 37 it is therefore necessary to verify whether the sperm are undergoing apoptosis. We focused on the intrinsic (mitochondria-dependent) pathway, which involves, for example, both pro-and anti-apoptotic members of the Bcl-2 family and especially on the general apoptotic features, as there is clearly much more information at that level. 32 The Bcl-2 family is the main regulator of the mitochondrial apoptosis pathway activating a series of downstream genes to regulate apoptosis. 38, 39 Bcl-2 is an anti-apoptotic protein whereas Bax promotes apoptosis and is the main mediator of mitochondrial pathways. 40 A series of regulations of the mitochondrial apoptosis pathway eventually leads to the activation of caspase 3, which induces apoptosis. 41 Our results showed that the expression levels of Bax and cleaved caspase 3 increased, whereas the expression level of Bcl-2 decreased in Tppp2 −/− mice sperm, which showed that the deletion of TPPP2 might activate the mitochondrial apoptotic pathways leading to lower sperm counts in Tppp2 −/− male mice.
In summary, TPPP2 deficiency impaired male fertility, which may relate to the decrease of ATP synthesis and the increase of sperm apoptosis. In contrast to TPPP1 and TPPP3, which are linked to microtubules, TPPP2 distributes homogeneously within the cytosol of cells. This indicates that instead of affecting microtubules, TPPP2
functions in another way. Here, considering that TPPP2 has no domains with known function, we identified its potential interaction protein, eEf1b, to assist in explaining the mechanism of action of TPPP2. EEf1b, a subtype of eEF1, plays an important role in the extension of protein translation. 42 We speculate that by affecting the function of eEf1b, TPPP2 might intervene in the translation of a series of related proteins, which participate in or regulate, the structure and function of mitochondria, thus affecting ATP production and apoptosis of spermatozoa.
This study used a Tppp2 KO mouse model and human sperm samples to demonstrate the important role of TPPP2 in male fertility. Our results demonstrated that TPPP2 is essential for sperm function. TPPP2 is likely to be a potential pathogenic factor in male oligoasthenozoospermia. The detailed mechanism of TPPP2's involvement in regulating sperm function will be clarified in further studies.
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